News | January 04, 2023
Harbor Healthcare advises a California long-term care pharmacy on its sale & strategic partnership
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
To create leading company developing medicines targeting metalloenzymes
The company is one of the most profitable companies manufacturing speciality chemicals in India
Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year
The term of O&M is for 15 years with a lock in period of 5 years for the Company and 15 years for VHPL & Bharathi Education trust.
Having a healthy gut is key as it permits the body to build a stronger immune system
Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism
The new facility will be able to handle four times as many patients as the previous facility.
Cipla and Ethris partner for the development of mRNA-based therapies
Subscribe To Our Newsletter & Stay Updated
